Seamless Therapeutics –Next generation ofgene editing

Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach, to restore health in patients with severe conditions in a safe and precise manner.

Its technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. The company is applying its proprietary know-how to develop a pipeline of disease modifying product candidates across a broad spectrum of indications, to expand the therapeutic potential of gene editing.